The UK government has announced a £5 million partnership with the RBM Partnership to End Malaria (RBM) to support global efforts to combat malaria.
The new initiative aims to support RBM in its efforts to bring together global leaders to fight malaria, with a focus on tackling resistance to malaria treatments and controlling the disease in Cameroon, Nigeria, Tanzania, and Uganda.
The partnership comes at a critical time, as progress against malaria has stalled in recent years, and the world is off track to meet the Sustainable Development Goal (SDG) target of ending the malaria epidemic by 2030.
According to Minister for Development Anneliese Dodds, the UK’s partnership with RBM will help “reenergise global efforts to tackle the epidemic” and ultimately save lives and unlock billions in economic growth.
“Malaria is a devastating disease that affects millions of people around the world, particularly in Africa,” Dodds said. “The UK is committed to supporting global efforts to combat malaria, and our partnership with RBM is a crucial step towards achieving this goal.”
The UK is also supporting research into new tools to prevent and treat malaria, including two malaria vaccines developed by British scientists that have the potential to save millions of lives.
Reducing malaria cases by 90% by 2030 could boost GDP by over $142 billion in malaria-endemic countries, making this partnership a crucial step towards unlocking growth in the Global South.
